Thomas Roberts, one of the founding members of the Multidisciplinary Association for Psychedelic Studies (MAPS), shares his extensive knowledge of psychedelics and his opinions on the future of psychedelic therapy. We discuss the directions that psychedelic research needs to take, and the reason why public benefit corporations will be the way forward for a burgeoning psychedelic industry.
- Why mystical psychedelic experiences are not necessarily the same as experiences designed to enhance problem solving.
- How psychedelics could be enhancing our immune systems, and why future research should examine this.
- Imagining a future psychedelic industry that doesn’t charge for substances, but for services like therapeutic guidance and integration.
THIS WEEK IN PSYCHEDELICS
Spaces still available on the Synthesis Retreat in Amsterdam!
New study shows that over 95% of cancer patients given medical cannabis report benefits including better sleep, reduced pain and improved appetite.
Harm reduction organisation The Loop have started crowdfunding to allow city-centre drug testing locations to open across the UK. They already offer drug testing services at UK festivals and clubs, and have had the full support of the police – despite having no government approval or funding.
If you’re buying Kratom in the US – be aware that dozens of people have become ill from Salmonella, and it’s been linked to contaminated Kratom powder. A specific supplier hasn’t been identified yet.
Sign up for our extensive Microdosing Course to gain access to expert interviews, curated microdosing resources, and an exclusive microdosing community!